Oramed Pharmaceuticals Inc

ORMP's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

ORMP Growth rates comparisons

Looking into Oramed Pharmaceuticals Inc growth rates, revenue grew by 0.15 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 2135

Major Pharmaceutical Preparations industry recorded growth of revenues by 0.82 %

Oramed Pharmaceuticals Inc 's net income grew by 28.94 % in III. Quarter 2022 year on year, above company average,

• More on ORMP's Growth

ORMP's Valuation comparisons

Oramed Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Oramed Pharmaceuticals Inc PEG ratio is at 0.07 Oramed Pharmaceuticals Inc realized cash outflow of $ -1.01per share in trailing twelve-month period.

Company

2.29

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 31.18.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.56.

• More on ORMP's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	3.92

ORMP's Valuation comparisons

Company

2.29

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 31.18.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.56.

Oramed Pharmaceuticals Inc Price to Book Ratio is at 0.55 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on ORMP's Valuation

• Market Capitalization (Millions $)	84
• Shares Outstanding (Millions)	39
• Employees	-
• Revenues (TTM) (Millions $)	3
• Net Income (TTM) (Millions $)	37
• Cash Flow (TTM) (Millions $)	-40
• Capital Exp. (TTM) (Millions $)	0
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	3.92

• Market Capitalization (Millions $)	84
• Shares Outstanding (Millions)	39
• Employees	-
• Revenues (TTM) (Millions $)	3
• Net Income (TTM) (Millions $)	37
• Cash Flow (TTM) (Millions $)	-40
• Capital Exp. (TTM) (Millions $)	0

ORMP's Profitability Comparisons
Oramed Pharmaceuticals Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2022 to 1200.73 % from 1693.92 % in II. Quarter. Oramed Pharmaceuticals Inc net profit margin of 1063.49 % is currently ranking no. 6 in Major Pharmaceutical Preparations industry, ranking no. 10 in Healthcare sector and number 35 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	25.44
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	0.06
• Asset Turnover Ratio (TTM)	0.02
• Inventory Turnover Ratio (TTM)	-

ORMP's Profitability Comparisons

Oramed Pharmaceuticals Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2022 to 1200.73 % from 1693.92 % in II. Quarter.

Oramed Pharmaceuticals Inc net profit margin of 1063.49 % is currently ranking no. 6 in Major Pharmaceutical Preparations industry, ranking no. 10 in Healthcare sector and number 35 in S&P 500.

• More on ORMP's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MNPR's Profile Stock Price MNPR's Financials Business Description Fundamentals Charts & Quotes MNPR's News Suppliers MNPR's Competitors Customers & Markets Economic Indicators MNPR's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071